CIPLA's weekly performance was disappointing, with a return of -3.29% and a Sharpe Ratio of -3.21, indicating poor risk-adjusted returns. The stock's volatility was moderate at 4.12%, but its Max Drawdown of -3.29% suggests a significant decline in value. Compared to its peers, CIPLA underperformed SUNPHARMA and GRASIM, but was outperformed by DIVISLAB. Overall, the stock was relatively risky this week.

[Volatility: 4.12%]